Physician profile
Sara E Turner
NPI 1740795566
$4,622.33
in general payments reported to CMS, 2019-2025
16 companies · $847 in 2025
The $847 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,491 · 2022: $948 · 2023: $455 · 2024: $881 · 2025: $847.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,183.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $1,850.51 | 2021-2023 | Tepezza |
| Amgen INC. | $736.63 | 2024-2025 | Tepezza |
| Biotissue Holdings INC. | $694.81 | 2021-2024 | |
| Ani Pharmaceuticals, INC. | $229.23 | 2023-2025 | Purified Cortrophin Gel |
| Tarsus Pharmaceuticals, INC. | $195.20 | 2025 | Xdemvy |
| Novo Nordisk INC | $143.19 | 2022-2024 | Wegovy, Saxenda |
| Allergan, INC. | $142.40 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $110.52 | 2022 | |
| Arcutis Biotherapeutics, INC. | $105.43 | 2024 | Zoryve |
| Axogen | $103.64 | 2023 | Avance Nerve Graft |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $89.55 | 2025 | Xifaxan |
| Galderma Laboratories, L.P. | $69.30 | 2024-2025 | |
| Mallinckrodt Hospital Products INC. | $50.68 | 2024 | Acthar |
| Regeneron Healthcare Solutions, INC. | $43.46 | 2023-2024 | Libtayo |
| Dompe US, INC. | $30.59 | 2025 | Oxervate |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $27.19 | 2024 | Grafix Pl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.